See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2017_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 192,695,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,585,000 |
| 3 | remainder_Assets | 1,080,000 |
| 4 | LiabilitiesCurrent | 19,647,000 |
| 5 | LiabilitiesNoncurrent | 100,000 |
| 6 | remainder_Liabilities | 7,542,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,075,000 |
| 9 | ResearchAndDevelopmentExpense | 50,381,000 |
| 10 | remainder_Expenses | 10,141,000 |
| 11 | remainder_Revenues | 300,000 |
| 12 | remainder_NetIncome | 27,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 204,360,000 |
| 1 | Liabilities | 27,289,000 |
| 2 | Expenses | 89,597,000 |
| 3 | Revenues | 300,000 |
| 4 | StockholdersEquity | 177,071,000 |
| 5 | NetIncome | -89,270,000 |
| 6 | ComprehensiveNetIncome | -89,272,500 |
| 7 | BaseVar | 160,789,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.56 |
| 9 | EconomicCapitalRatio | 3.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
